scispace - formally typeset
D

Diane M. Citron

Researcher at Michigan State University

Publications -  168
Citations -  8921

Diane M. Citron is an academic researcher from Michigan State University. The author has contributed to research in topics: Bacteroides fragilis & Anaerobic bacteria. The author has an hindex of 47, co-authored 166 publications receiving 8185 citations. Previous affiliations of Diane M. Citron include University of California & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Bacteriologic Analysis of Infected Dog and Cat Bites

TL;DR: Infected dog and cat bites have a complex microbiologic mix that usually includes pasteurella species but may also include many other organisms not routinely identified by clinical microbiology laboratories and not previously recognized as bite-wound pathogens.
Journal ArticleDOI

Selective and differential medium for isolation of Clostridium difficile.

TL;DR: A selective and differential agar medium that contains cycloserine, cefoxitin, fructose, and egg yolk (CCFA) was developed to facilitate the isolation of C. difficile from fecal specimens and was found to be the most sensitive and selective of these media for the recovery of the bacterium.
Journal ArticleDOI

Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938.

TL;DR: Based on phenotypic, chemotaxonomic and phylogenetic analyses, novel genus Clostridioides gen. nov. is proposed for Clastridium difficile as Clostidioides difficILE gen. comb.
Journal ArticleDOI

Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.

TL;DR: Ertapenem and piperacillin-tazobactam were each active against >98% of the enteric gram-negative rods, methicillin-sensitive S. aureus, and anaerobes, and antibiotic susceptibility results can help to inform therapeutic choices.
Journal ArticleDOI

Effects of control interventions on Clostridium difficile infection in England: an observational study

TL;DR: Limiting fluoroquinolone prescribing appears to explain the decline in incidence of C difficile infections, above other measures, in Oxfordshire and Leeds, England.